相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Kushal Prajapati et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System
Wei-Chen Huang et al.
JOURNAL OF IMMUNOLOGY (2017)
Clinical trials of CAR-T cells in China
Bingshan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Jun Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Erhao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
Aaron E. Foster et al.
MOLECULAR THERAPY (2017)
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
Xinru Wei et al.
ONCOIMMUNOLOGY (2017)
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+hepatocellular carcinoma (r/r GPC3+HCC).
Bo Zhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
NKG2D stimulation of CD8+ T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice
Inga Kavazovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor
Xuemei Jiang et al.
FRONTIERS IN IMMUNOLOGY (2016)
Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2
Tessa Gargett et al.
CYTOTHERAPY (2015)
Quantitative evaluation of the immunodeficiency of a mouse strain by tumor engraftments
Wei Ye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8+ T cells
Emily Whitman et al.
MOLECULAR IMMUNOLOGY (2015)
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation
Ben J. E. Raveney et al.
NATURE COMMUNICATIONS (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
NKG2D signaling in cancer immunosurveillance
Alejandro Lopez-Soto et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Sonia Guedan et al.
BLOOD (2014)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti et al.
IMMUNOLOGICAL REVIEWS (2014)
CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors
Jiemiao Hu et al.
MOLECULAR CANCER (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer exosomes and NKG2D receptor-ligand interactions: Impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance
Lucia Mincheva-Nilsson et al.
SEMINARS IN CANCER BIOLOGY (2014)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bystander-Activated Memory CD8 T Cells Control Early Pathogen Load in an Innate-like, NKG2D-Dependent Manner
Talyn Chu et al.
CELL REPORTS (2013)
T-bet: a bridge between innate and adaptive immunity
Vanja Lazarevic et al.
NATURE REVIEWS IMMUNOLOGY (2013)
RAE-1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition
Mary A. Markiewicz et al.
IMMUNITY (2012)
Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction
Maya Caroline Andre et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+ T cells
Andreas A. Hombach et al.
ONCOIMMUNOLOGY (2012)
Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy
De-Gang Song et al.
ONCOIMMUNOLOGY (2012)
In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
De-Gang Song et al.
CANCER RESEARCH (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
Bipulendu Jena et al.
BLOOD (2010)
Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma
Amorette Barber et al.
EXPERIMENTAL HEMATOLOGY (2008)
NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells:: Evidence for a protective role in virus-induced encephalitis
Kevin B. Walsh et al.
JOURNAL OF VIROLOGY (2008)
Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer
Arnorette Barber et al.
CANCER RESEARCH (2007)
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Claudia M. Kowolik et al.
CANCER RESEARCH (2006)
Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor
Tong Zhang et al.
CANCER RESEARCH (2006)
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells
M Karimi et al.
JOURNAL OF IMMUNOLOGY (2005)
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
MR Verneris et al.
BLOOD (2004)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
T Nakatsura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
分享论文
